Radioligand therapy is a form of precise cancer treatment that targets specific cells with a radioactive substance. It’s used to treat prostate cancer and some types of neuroendocrine cancer, delivering powerful results with minimal impact on patient quality of life. Dr. Michael Morris helped develop radioligands for prostate cancer, and he tells Chuck and Alicia about the huge promise he sees in these treatments going forward.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Charles Ryan MD, Alicia Morgans MD MPH. Innehållet i podden är skapat av Charles Ryan MD, Alicia Morgans MD MPH och inte av, eller tillsammans med, Poddtoppen.